149 related articles for article (PubMed ID: 17331388)
1. [The efficacy and safety of tulobuterol tape in mild and moderate persistent asthma patients].
Su N; Lin JT; Yang M; Chen X; He J; He QY; Cao ZL; Chen BY; Xiao Y; Yan XX
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):39-42. PubMed ID: 17331388
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
Horiguchi T; Kondo R; Miyazaki J; Fukumokto K; Torigoe H
Arzneimittelforschung; 2004; 54(5):280-5. PubMed ID: 15212190
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma.
Nishiyama O; Taniguchi H; Kondoh Y; Kimura T; Kato K; Kume H; Shimokata K
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1016-21. PubMed ID: 17042908
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of tulobuterol patch in patients with mild or moderate persistent bronchial asthma-effects of long-term treatment on airway inflammation and hypersensitivity].
Horiguchi T; Kondo R; Miyazaki J; Torigoe H; Tachikawa S
Nihon Kokyuki Gakkai Zasshi; 2004 Feb; 42(2):132-7. PubMed ID: 15007912
[TBL] [Abstract][Full Text] [Related]
5. Effects of transdermal tulobuterol in pediatric asthma patients on long-term leukotriene receptor antagonist therapy: results of a randomized, open-label, multicenter clinical trial in Japanese children aged 4-12 years.
Katsunuma T; Fujisawa T; Nagao M; Akasawa A; Nomura I; Yamaoka A; Kondo H; Masuda K; Yamaguchi K; Terada A; Ikeda M; Nishioka K; Adachi Y; Kurihara K
Allergol Int; 2013 Mar; 62(1):37-43. PubMed ID: 23000726
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy and safety of tulobuterol patch versus oral salbutamol sulfate in children with mild or moderate acute attack of bronchial asthma: a comparative study].
Lin Q; Liu QH; Bao YX
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jun; 15(6):462-5. PubMed ID: 23791063
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids.
Fujimoto K; Komatsu Y; Yasuo M; Urushihata K; Kubo K
J Asthma; 2006 Sep; 43(7):501-7. PubMed ID: 16939989
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
Ichinose M; Seyama K; Nishimura M; Fukuchi Y; Nagai A; Mishima M; Kubo K;
Respir Med; 2010 Feb; 104(2):267-74. PubMed ID: 19875277
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic equivalence between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma.
Fugleholm AM; Ibsen TB; Laxmyr L; Svendsen UG
Eur Respir J; 1993 Nov; 6(10):1474-8. PubMed ID: 8112441
[TBL] [Abstract][Full Text] [Related]
10. [Effect of a patch formulation of tulobuterol on cough scores and PEF in patients with cough variant asthma].
Fujimori K; Suzuki E; Gejyo F
Arerugi; 2000 Aug; 49(8):658-61. PubMed ID: 11021018
[No Abstract] [Full Text] [Related]
11. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
Medley H; Orozco S; Allen A
Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
[TBL] [Abstract][Full Text] [Related]
12. Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Tamura G; Ichinose M; Fukuchi Y; Miyamoto T
Allergol Int; 2012 Jun; 61(2):219-29. PubMed ID: 22270072
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the circadian rhythm in peak expiratory flow of nocturnal asthma following nighttime transdermal beta2-adrenoceptor agonist tulobuterol chronotherapy.
Burioka N; Miyata M; Endo M; Fukuoka Y; Suyama H; Nakazaki H; Igawa K; Shimizu E
Chronobiol Int; 2005; 22(2):383-90. PubMed ID: 16021849
[TBL] [Abstract][Full Text] [Related]
14. Treatment of asthma with tulobuterol or albuterol in school-age children.
Le Bourgeois M; de Blic J; Chauvin JP; Scheinmann P; Paupe J
Clin Ther; 1990; 12(6):513-9. PubMed ID: 2289220
[TBL] [Abstract][Full Text] [Related]
15. A 3-month comparison of formoterol with terbutaline via turbuhaler. A placebo-controlled study.
Ekström T; Ringdal N; Tukiainen P; Runnerström E; Soliman S
Ann Allergy Asthma Immunol; 1998 Sep; 81(3):225-30. PubMed ID: 9759798
[TBL] [Abstract][Full Text] [Related]
16. Formoterol used as needed in patients with intermittent or mild persistent asthma.
Chuchalin A; Kasl M; Bengtsson T; Nihlen U; Rosenborg J
Respir Med; 2005 Apr; 99(4):461-70. PubMed ID: 15763453
[TBL] [Abstract][Full Text] [Related]
17. Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler.
Kobayashi Y; Yasuba H; Kudou M; Kita H
J Asthma; 2007 Mar; 44(2):77-81. PubMed ID: 17454319
[TBL] [Abstract][Full Text] [Related]
18. A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma.
Inoue H; Niimi A; Matsumoto H; Ito I; Oguma T; Otsuka K; Takeda T; Nakaji H; Tajiri T; Iwata T; Nagasaki T; Mishima M
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):21-29. PubMed ID: 27718262
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of tulobuterol aerosol in childhood asthma.
Sienra-Monge JJ; Graham-Zapata LF; Del Rio-Navarro BE
J Int Med Res; 1990; 18(6):483-8. PubMed ID: 2292330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
